Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Sensitization of glioma cells by X-linked inhibitor of apoptosis protein knockdown.

Lopez PL, Filippi-Chiela EC, Silva AO, Cordero EA, Garcia-Santos D, Pelegrini AL, Reder GM, Barbieri NL, Lenz G.

Oncology. 2012;83(2):75-82. doi: 10.1159/000337978. Epub 2012 Jun 29.

PMID:
22760199
2.

Down-regulation of XIAP by AEG35156 in paediatric tumour cells induces apoptosis and sensitises cells to cytotoxic agents.

Holt SV, Brookes KE, Dive C, Makin GW.

Oncol Rep. 2011 Apr;25(4):1177-81. doi: 10.3892/or.2011.1167. Epub 2011 Jan 31.

PMID:
21286665
3.

Efficacy of MDM2 inhibitor MI-219 against lung cancer cells alone or in combination with MDM2 knockdown, a XIAP inhibitor or etoposide.

Zheng M, Yang J, Xu X, Sebolt JT, Wang S, Sun Y.

Anticancer Res. 2010 Sep;30(9):3321-31.

PMID:
20944104
4.
5.

XIAP gene downregulation by small interfering RNA inhibits proliferation, induces apoptosis, and reverses the cisplatin resistance of ovarian carcinoma.

Ma JJ, Chen BL, Xin XY.

Eur J Obstet Gynecol Reprod Biol. 2009 Oct;146(2):222-6. doi: 10.1016/j.ejogrb.2009.06.011. Epub 2009 Sep 15.

PMID:
19758744
6.

X-linked inhibitor regulating TRAIL-induced apoptosis in chemoresistant human primary glioblastoma cells.

Roa WH, Chen H, Fulton D, Gulavita S, Shaw A, Th'ng J, Farr-Jones M, Moore R, Petruk K.

Clin Invest Med. 2003 Oct;26(5):231-42.

PMID:
14596484
7.

Doxorubicin induces cell death in breast cancer cells regardless of Survivin and XIAP expression levels.

Nestal de Moraes G, Vasconcelos FC, Delbue D, Mognol GP, Sternberg C, Viola JP, Maia RC.

Eur J Cell Biol. 2013 Aug-Sep;92(8-9):247-56. doi: 10.1016/j.ejcb.2013.08.001. Epub 2013 Aug 31.

PMID:
24064045
8.

Topotecan triggers apoptosis in p53-deficient cells by forcing degradation of XIAP and survivin thereby activating caspase-3-mediated Bid cleavage.

Tomicic MT, Christmann M, Kaina B.

J Pharmacol Exp Ther. 2010 Jan;332(1):316-25. doi: 10.1124/jpet.109.159962. Epub 2009 Oct 7.

9.

Simultaneous activation of p53 and inhibition of XIAP enhance the activation of apoptosis signaling pathways in AML.

Carter BZ, Mak DH, Schober WD, Koller E, Pinilla C, Vassilev LT, Reed JC, Andreeff M.

Blood. 2010 Jan 14;115(2):306-14. doi: 10.1182/blood-2009-03-212563. Epub 2009 Nov 6.

10.

Cord blood stem cell-mediated induction of apoptosis in glioma downregulates X-linked inhibitor of apoptosis protein (XIAP).

Dasari VR, Velpula KK, Kaur K, Fassett D, Klopfenstein JD, Dinh DH, Gujrati M, Rao JS.

PLoS One. 2010 Jul 28;5(7):e11813. doi: 10.1371/journal.pone.0011813.

11.
12.

D,L-Sulforaphane-induced cell death in human prostate cancer cells is regulated by inhibitor of apoptosis family proteins and Apaf-1.

Choi S, Lew KL, Xiao H, Herman-Antosiewicz A, Xiao D, Brown CK, Singh SV.

Carcinogenesis. 2007 Jan;28(1):151-62. Epub 2006 Aug 18.

13.

c-IAP1 is overexpressed in HL-60 cells selected for doxorubicin resistance: effects on etoposide-induced apoptosis.

Vaziri SA, Grabowski DR, Tabata M, Holmes KA, Sterk J, Takigawa N, Bukowski RM, Ganapathi MK, Ganapathi R.

Anticancer Res. 2003 Sep-Oct;23(5A):3657-61.

PMID:
14666661
14.

Sensitization of cervix cancer cells to Adriamycin by Pentoxifylline induces an increase in apoptosis and decrease senescence.

Bravo-Cuellar A, Ortiz-Lazareno PC, Lerma-Diaz JM, Dominguez-Rodriguez JR, Jave-Suarez LF, Aguilar-Lemarroy A, del Toro-Arreola S, de Celis-Carrillo R, Sahagun-Flores JE, de Alba-Garcia JE, Hernandez-Flores G.

Mol Cancer. 2010 May 19;9:114. doi: 10.1186/1476-4598-9-114.

15.

The CD95/CD95 ligand system is not the major effector in anticancer drug-mediated apoptosis.

Tolomeo M, Dusonchet L, Meli M, Grimaudo S, D'Alessandro N, Papoff G, Ruberti G, Rausa L.

Cell Death Differ. 1998 Sep;5(9):735-42.

17.

Specific down-regulation of XIAP with RNA interference enhances the sensitivity of canine tumor cell-lines to TRAIL and doxorubicin.

Spee B, Jonkers MD, Arends B, Rutteman GR, Rothuizen J, Penning LC.

Mol Cancer. 2006 Sep 5;5:34.

18.

Akt and XIAP regulate the sensitivity of human uterine cancer cells to cisplatin, doxorubicin and taxol.

Gagnon V, Van Themsche C, Turner S, Leblanc V, Asselin E.

Apoptosis. 2008 Feb;13(2):259-71.

PMID:
18071906
19.

Caspase-3 cleaves XIAP in a positive feedback loop to sensitize melanoma cells to TRAIL-induced apoptosis.

Hörnle M, Peters N, Thayaparasingham B, Vörsmann H, Kashkar H, Kulms D.

Oncogene. 2011 Feb 3;30(5):575-87. doi: 10.1038/onc.2010.434. Epub 2010 Sep 20.

PMID:
20856198
20.

Specific downregulation of bcl-2 and xIAP by RNAi enhances the effects of chemotherapeutic agents in MCF-7 human breast cancer cells.

Lima RT, Martins LM, Guimarães JE, Sambade C, Vasconcelos MH.

Cancer Gene Ther. 2004 May;11(5):309-16.

PMID:
15031723
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk